Sorry for the little break. I am hopefully back and at it. The sector has not done great but it does not look too bad either. There have been lower lows and lower highs, which signals a clear downtrend but it seems to have been pretty orderly and we are now back to the old […]
August 15th Biotech Update
A slow start to the week but that is not necessarily bad. The sector has been strong and there has been nothing to change it. I think the biggest news has been outside the sector with the decline in the Empire State index, but I imagine that might not been a massive surprise (perhaps the […]
August 10th Biotech Update
Did we have that pullback that refreshed? Sort of. We went down to what was resistance and have bounced but it was a quick little move. In some ways, a move down to the $87 level on the XBI would be the former resistance and I will be really looking to see if we make […]
August 8th Biotech Update
A good start to the week and it should continue the momentum for the sector. While I think we still can move on the news, it is also the case that the sector has had a nice run recently. Nothing goes up (or down forever) and the longer the run, the better the news has […]
August 4th Biotech Update
Are we finally starting to see the wheels of M&A loosen? Perhaps. We got some this morning as well as a new rumor. It is enough to move the sector (at least a little). We are definitely in a different spot as the news is actually moving the sector higher. It was not that long […]
August 3rd Biotech Update
We started the week at the bottom of the range and within three days we are at the top of the range. I find days like this a little tough to judge. Big positive moves like this make it feel like there is very strong momentum but when they smack against the top of a […]
The XBI – A Short Term Outlook
Many are asking if the XBI is done with the bounce and will drop back to test the 52-week low around $61, or it is still in a consolidation mode and will continue the recovery and move upward again! Here is my outlook for the biotech sector these days. The XBI used as a leading […]
August 1st Biotech Update
We have some more earnings this week but the lack of exciting launches to track make them a little less exciting. Of course, there could be some unexpected misses (see below) but I generally expect earnings to be more or less in than with expectations. The sector has been essentially rangebound the entire month […]
July 29th Biotech Update
I have had family in town that has changed my schedule and so it has been slow on the updates this week. There is growing optimism in the sector and I suspect that we could outperform the rest of the year. Maybe I am crazy but as long as the fundamentals do not crash in […]
July 21st Biotech Update
A slow week but a good week for the sector. We are entering earnings and that might provide a little boost or drag but it has been awhile since an earnings season really seemed to impact the sector. They can affect individual stocks but the quarters where you have broad read throughs seem to have […]
July 14th Biotech Update
The sector seems to be doing ok as we inch closer to earnings season. It will be interesting to see how the sector moves on earnings as there is nothing that should really surprise anyone. There are still some issues outside the companies that could impact trading. There is some drug pricing reforms being discussed […]
July 12th Biotech Update
No real news to start the week the juice the sector and so far we have simply followed the broader market lower. This could/should be the pullback that refreshes as we have had a nice run higher and a pullback to the $78 level makes sense. Of course that needs to hold and we need […]
July 8th Biotech Update
I am not sure if we end up green today or not but I think we are finally in a decent position for the sector. There is a virtuous position where a sector has outperformed but investor are underweighted it and so they are underperforming the market. They need to get into the sector to […]
July 7th Biotech Update
Are we going to get the deal? It looks like it and it looks like the sector is responding well. To be fair the sector was already doing well before the report, so this looks like a continuation of that move. I think it is relatively safe to say that the sector finally has created […]
July 5th Biotech Update
Not the ideal return from vacation for me or the end of a holiday extended weekend for everyone else. It would have been really nice to have started this week with a buyout but there really is not a ton of news to start the week. Ideally we can reverse this early weakness and build […]
June 21st Biotech Update
Are we finally getting some love in the sector? The market and sector were very oversold and we were due for a bounce in both. We seem to be getting some nice momentum in both (and I would add cryptocurrency which adds to my belief that it really might be a proxy now for risk […]
June 15th Biotech Update
So it is a good start to the morning and yesterday was OK in that we did not crash more. I would not really pay any attention to the morning moves as the more important trading action will be after the Fed announcement. Obviously expectations are for a rate hike and speculation is that it […]
June 14th Biotech Update
The market is a mess. We had treasuries invert on Friday, which is a favorite signal of an impending recession. To be fair the treasury inversion over predicts recessions and so there have been many instances where nothing happened after an inversion. All that being said rising rates and high inflation is probably bound to […]
June 8th Biotech Update
I guess I brought some good vibes back from my vacation. I still would say that we are not ever close to saying that an uptrend is in play but these strong days are the necessary condition to start that trend. We are at a level where additional upside gets us starting to think more […]
June 7th Biotech Update
I am back from my little vacation and have some catching up to do. The sector seems to be looking for direction as it bounced around from my perspective. I did not follow its movements closely but from the distance of the beach it looks as if the sector has not made a decision to […]
